Investment Banking

Bankers see ‘Darwinian’ merger frenzy next year after raking in the most fees since 2007

Global banks earned $87bn in fees in 2020, and one investment banker said that boom is set to continue as the strongest companies get even stronger

 AstraZeneca will spend $39bn on US biotech company Alexion
AstraZeneca will spend $39bn on US biotech company Alexion Photo: Getty Images

Top dealmakers say 2021 will again generate a bumper fee haul, after the Covid-19 pandemic ushered in a surprise surge in capital raisings and megadeals. 

Global banks earned $87bn in fees in 2020, according to data provider Dealogic, their largest haul in 13-years.  The boom was driven by companies tapping the equity markets for cash to shore up their balance sheets to weather the early days of the pandemic, while big M&A deals and initial public offerings returned in the second half of the year.

WSJ Logo